In addition, our study showed for the first time that silencing LINC00641 suppressed the proliferation and invasion abilities of RCC cells by targeting the LINC00641/miRNA-340-5p axis, which indicated that LINC00641 could be used as a potential therapeutic target for the precise treatment of RCC. This evidence concerns the gene LINC00641 and renal cell carcinoma.